In in vitro models of breast cancer, the role of leptin on proliferation, migration, epithelial-mesenchymal transition (EMT), and cell invasion by activating signaling pathways such as ERK, STAT3, and FAK-Src has been described31,39,40. This evidence concerns the gene LEP and breast carcinoma.